v3.25.1
Stockholders’ Equity (Details) - USD ($)
3 Months Ended 12 Months Ended
Jan. 21, 2025
Nov. 25, 2024
Apr. 23, 2024
Oct. 10, 2023
Dec. 13, 2013
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Aug. 09, 2016
Stockholders’ Equity [Line Items]                  
Preferred stock, shares authorized         5,000,000 5,000,000   5,000,000  
Preferred stock, par value (in Dollars per share)         $ 0.001 $ 0.001   $ 0.001  
Preferred stock, voting rights         50        
Receive per share (in Dollars per share)         $ 1        
Preferred stock shares outstanding           2,000,000   2,000,000  
Outstanding percentage           51.00%      
Guarantee terms           18 months      
Stock shareholder (in Dollars)       $ 15,000          
Common stock per share (in Dollars per share)       $ 0.15   $ 0.001   $ 0.001  
Stock options awards shares 105,000         1,250,000      
Stock option expense over the vesting period (in Dollars) $ 176,504                
Options outstanding           2,892,500   2,367,500  
Vested exercisable           2,121,250      
Unvested stock-based compensation expense (in Dollars)           $ 200,703      
Aggregate intrinsic value (in Dollars)              
Exercise price of underlying options (in Dollars per share)           $ 0.45      
Stock Redemption Agreement [Member]                  
Stockholders’ Equity [Line Items]                  
Purchased shares       100,000          
Stock Options [Member]                  
Stockholders’ Equity [Line Items]                  
Number of shares vested   8,750              
Expected dividend yield   0.00%              
Expected volatility   86.00%              
Risk-free interest rate   4.17%              
Expected term   6 years 6 months              
Stock option expense over the vesting period (in Dollars)   $ 35,506       $ 56,606 $ 16,494    
Options outstanding           2,892,500   2,367,500  
Vested exercisable               2,051,250  
Unvested stock-based compensation expense (in Dollars)               $ 80,805  
Aggregate intrinsic value (in Dollars)                
Exercise price of underlying options (in Dollars per share)               $ 0.54  
Board of Directors [Member]                  
Stockholders’ Equity [Line Items]                  
Shares purchased value (in Dollars)     $ 1,000,000            
Common Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Purchased shares               13,687  
Purchased share value (in Dollars)               $ 8,010  
Price per share (in Dollars per share)               $ 0.59  
Stock options awards shares           1,250,000   1,250,000  
2016 Plan [Member]                  
Stockholders’ Equity [Line Items]                  
Future issuance shares           8,357,500   8,882,500 10,000,000
Stock options awards shares 525,000         1,642,500   1,117,500  
Exercisable shares outstanding 525,000         871,250   826,250  
Common stock at an exercise price (in Dollars per share) $ 0.44                
Number of shares vested 8,750                
Expected dividend yield 0.00%                
Expected volatility 82.10%                
Risk-free interest rate 4.30%                
Expected term 6 years 6 months                
2016 Plan [Member] | Stock Options [Member]                  
Stockholders’ Equity [Line Items]                  
Company granted a stock option to purchase   105,000              
Common stock at an exercise price (in Dollars per share)   $ 0.49              
2014 Plan [Member]                  
Stockholders’ Equity [Line Items]                  
Stock options awards shares           1,250,000      
Exercisable shares outstanding           1,250,000   1,250,000  
Additional shares